Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 8/20 | 0.36 |
| ▸ | ADH1C | P00326 | 6/20 | 0.36 |
| ▸ | ADH1B | P00325 | 2/20 | 0.35 |
| ▸ | ADH7 | P40394 | 2/20 | 0.35 |
| ▸ | ADH4 | P08319 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL887171 | 1.00 | ADH1A (0.36) | ADH1AADH1CADH1BADH7ADH4 | |
| SCHEMBL887136 | 1.00 | ADH1A (0.36) | ADH1AADH1CADH1BADH7ADH4 | |
| SCHEMBL887172 | 1.00 | ADH1A (0.36) | ADH1AADH1CADH1BADH7ADH4 | |
| SCHEMBL2855078 | 1.00 | ADH1A (0.36) | ADH1AADH1CADH1BADH7ADH4 | |
| SCHEMBL28253445 | 0.94 | ADH1A (0.33) | ADH1AADH1CADH1BADH7ADH4 | |
| SCHEMBL1684034 | 0.90 | ADH1A (0.39) | ADH1AADH1CADH1BADH7ADH4 | |
| SCHEMBL2859214 | 0.90 | ADH1A (0.39) | ADH1AADH1CADH1BADH7ADH4 | |
| SCHEMBL1684031 | 0.90 | ADH1A (0.39) | ADH1AADH1CADH1BADH7ADH4 | |
| SCHEMBL1684030 | 0.90 | ADH1A (0.39) | ADH1AADH1CADH1BADH7ADH4 | |
| SCHEMBL1684033 | 0.90 | ADH1A (0.39) | ADH1AADH1CADH1BADH7ADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2876137-B1 | Binder compositions of aliphatic or cycloaliphatic dicarboxaldehydes and resorcinol | ROHM & HAAS (US) | 2019-08-07 | — | — | EP | claimed |
| WO-2019142208-A1 | AMBIENT TEMPERATURE CURABLE NON-ISOCYANATE POLYHYDROXYALKYLURETHANE MOIETIES WITH ALDEHYDE CROSS LINKER | Asian Paints Ltd. (IN) | 2019-07-25 | — | — | WO | claimed |
| EP-2200957-B2 | HYDROGENATION OF ALICYCLIC DIALDEHYDES TO ALICYCLIC DIOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-09-14 | — | — | EP | claimed |
| EP-2200957-B1 | HYDROGENATION OF ALICYCLIC DIALDEHYDES TO ALICYCLIC DIOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-12-26 | — | — | EP | claimed |
| US-8304583-B2 | Hydrogenation of aliphatic dialdehydes to aliphatic diols | DOW GLOBAL TECHNOLOGIES LLC | 2012-11-06 | — | — | US | claimed |
| US-20110098514-A1 | HYDROGENATION OF ALIPHATIC DIALDEHYDES TO ALIPHATIC DIOLS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2011-04-28 | — | — | US | claimed |
| US-6252121-B1 | SEPARATION OF CYCLIC REACTANTS, CORRESPONDING PRODUCTS, NONPOLAR SOLVENT, ORGANOPHOSPHORUS LIGANDS AND CATALYST COMPLEX MATERIALS FROM MULTIPHASE REACTION PRODUCT FLUID HAVING POLAR AND NONPOLAR PHASES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2001-06-26 | — | — | US | claimed |
| EP-3114164-B1 | LOWER TEMPERATURE CURE COATING COMPOSITIONS | KING INDUSTRIES INC (US) | 2025-07-02 | — | — | EP | disclosed |
| CN-106366897-B | Environmentally curable compositions for making coatings with moisture and corrosion resistance and methods of use | 陶氏环球技术有限责任公司 | 2021-06-04 | — | — | CN | disclosed |
| EP-3387080-B1 | CROSSLINKABLE COMPOSITION AND COATING MADE THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-05-12 | — | — | EP | disclosed |
| CN-106008965-B | Ambient temperature curable isocyanate-free compositions for preparing crosslinked polyurethanes | 陶氏环球技术有限责任公司 | 2021-04-30 | — | — | CN | disclosed |
| EP-3010948-B1 | A CROSS-LINKABLE COATING COMPOSITION AND METHOD OF PRODUCING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-03-03 | — | — | EP | disclosed |
| US-10723889-B2 | Ambient cure, fast dry automotive refinish primer surfacer compositions and methods of use | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-07-28 | — | — | US | disclosed |
| WO-2009114383-A1 | POLYPHENOLIC COMPOUNDS AND EPOXY RESINS COMPRISING CYCLOALIPHATIC MOIETIES AND PROCESS FOR THE PRODUCTION THEREOF | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-09-17 | — | — | WO | disclosed |
| WO-2009114469-A1 | AROMATIC POLYCYANATE COMPOUNDS AND PROCESS FOR THE PRODUCTION THEREOF | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-09-17 | — | — | WO | disclosed |
| WO-2009035838-A2 | HYDROGENATION OF ALIPHATIC DIALDEHYDES TO ALIPHATIC DIOLS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-03-19 | — | — | WO | disclosed |
| EP-1764353-A1 | Improved metal-ligand complex catalysed processes | Union Carbide Chemical & Plastics Technology Corporation (US) | 2007-03-21 | — | — | EP | disclosed |
| EP-1204623-A2 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2002-05-15 | — | — | EP | disclosed |
| US-6252121-B1 | SEPARATION OF CYCLIC REACTANTS, CORRESPONDING PRODUCTS, NONPOLAR SOLVENT, ORGANOPHOSPHORUS LIGANDS AND CATALYST COMPLEX MATERIALS FROM MULTIPHASE REACTION PRODUCT FLUID HAVING POLAR AND NONPOLAR PHASES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2001-06-26 | — | — | US | disclosed |
| WO-2001007382-A2 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2001-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098514-A1 | HYDROGENATION OF ALIPHATIC DIALDEHYDES TO ALIPHATIC DIOLS | ADH1C, ADH1A, DHCR24 | ADH1A 2/4885ADH1C 1/4885ADH1B 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.